Future directions in palliative thoracic radiotherapy
- PMID: 22156793
- DOI: 10.1097/SPC.0b013e32834de6bd
Future directions in palliative thoracic radiotherapy
Abstract
Purpose of review: Recent systematic review, practice guidelines, and consensus statements have summarized the known clinical trial information with regards to the appropriate use of external-beam radiation, brachytherapy, and concurrent chemotherapy (with external-beam radiotherapy) in the palliation of chest symptoms with thoracic radiotherapy. The purpose of this review is to describe our present knowledge with regards to palliative thoracic radiotherapeutic maneuvers and to identify potential areas for future research inquiry consistent with current knowledge gaps.
Recent findings: Two systematic reviews, one practice guideline, and one consensus statement based on published prospective clinical trials have demonstrated that palliative thoracic radiotherapy is an effective modality both in terms of symptom palliation and other important cancer outcomes. Evolving areas for future scientific inquiry include the role of advanced technologies such as intensity-modulated radiation therapy and image-guided radiation therapy, economic analyses as well as the creation of a common palliative endpoint that can be used for future clinical trials.
Summary: Robust clinical trial information and high-level knowledge-translation documents currently exist to guide radiotherapy practitioners to provide standard-of-care treatment for thoracic palliative scenarios.
Similar articles
-
Palliative endobronchial brachytherapy for non-small cell lung cancer.Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004284. doi: 10.1002/14651858.CD004284.pub3. Cochrane Database Syst Rev. 2012. PMID: 23235606 Free PMC article.
-
A systematic overview of radiation therapy effects in head and neck cancer.Acta Oncol. 2003;42(5-6):443-61. doi: 10.1080/02841860310014886. Acta Oncol. 2003. PMID: 14596506
-
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19. Eur J Cancer. 2007. PMID: 17182241
-
A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.Acta Oncol. 2003;42(5-6):605-19. doi: 10.1080/02841860310014435. Acta Oncol. 2003. PMID: 14596518
-
A systematic overview of radiation therapy effects in skeletal metastases.Acta Oncol. 2003;42(5-6):620-33. doi: 10.1080/02841860310014895. Acta Oncol. 2003. PMID: 14596519
Cited by
-
PPM1A as a key target of the application of Jiawei‑Maxing‑Shigan decoction for the attenuation of radiation‑induced epithelial‑mesenchymal transition in type II alveolar epithelial cells.Mol Med Rep. 2021 Nov;24(5):825. doi: 10.3892/mmr.2021.12465. Epub 2021 Sep 24. Mol Med Rep. 2021. PMID: 34558633 Free PMC article.
-
Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.Drug Des Devel Ther. 2015 Jun 22;9:3163-78. doi: 10.2147/DDDT.S80958. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26124639 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials